A detailed history of Oder Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Oder Investment Management, LLC holds 4,537 shares of ABBV stock, worth $743,342. This represents 0.78% of its overall portfolio holdings.

Number of Shares
4,537
Previous 5,045 10.07%
Holding current value
$743,342
Previous $781,000 5.76%
% of portfolio
0.78%
Previous 0.78%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $81,188 - $92,506
-508 Reduced 10.07%
4,537 $826,000
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $412 - $464
3 Added 0.06%
5,045 $781,000
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $2,137 - $2,474
16 Added 0.32%
5,042 $751,000
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $24,911 - $31,001
188 Added 3.89%
5,026 $677,000
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $14,316 - $16,487
-99 Reduced 2.01%
4,838 $771,000
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $7,745 - $9,288
-56 Reduced 1.12%
4,937 $798,000
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $18,252 - $20,934
-136 Reduced 2.65%
4,993 $670,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $705,852 - $897,369
5,129 New
5,129 $785,000
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $722,668 - $820,337
-6,792 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $28,722 - $31,998
273 Added 4.19%
6,792 $765,000
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $246,543 - $271,414
2,410 Added 58.65%
6,519 $706,000
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $330,733 - $446,525
4,109 New
4,109 $436,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $290B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Oder Investment Management, LLC Portfolio

Follow Oder Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oder Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oder Investment Management, LLC with notifications on news.